Outcome of HLA-matched related allogeneic hematopoietic stem cell transplantation for patients with acute leukemia in first complete remission treated in Eastern European centers. Better results in recent years

Author:

Giebel Sebastian,Labopin Myriam,Holowiecki Jerzy,Labar Boris,Komarnicki Mieczyslaw,Koza Vladimir,Masszi Tamas,Mistrik Martin,Lange Andrzej,Hellmann Andrzej,Vitek Antonin,Pretnar Joze,Mayer Jiri,Rzepecki Piotr,Indrak Karel,Wiktor-Jedrzejczak Wieslaw,Wojnar Jerzy,Krawczyk-Kulis Malgorzata,Kyrcz-Krzemien Slawomira,Rocha Vanderson

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Reference29 articles.

1. Thomas X, Boiron JM, Huguet F et al (2004) Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial. J Clin Oncol 22:4075–4086. doi: 10.1200/JCO.2004.10.050

2. Labar B, Suciu S, Zittoun R et al (2004) Allogeneic stem cell transplantation in acute lymphoblastic leukemia and non-Hodgkin’s lymphoma for patients <or = 50 years old in first complete remission: results of the EORTC ALL-3 trial. Haematologica 89:809–817

3. Goldstone AH, Richards SM, Lazarus HM et al (2007) In adults with standard-risk acute lymphoblastic leukemia (ALL) the greatest benefit is achieved from a matched sibling allogeneic transplant in first complete remission (CR) and an autologous transplant is less effective than conventional consolidation/maintenance chemotherapy in All patients: final results of the international ALL trial (MRC UKALL XII/ ECOG E2993). Blood 111:1827–1833. doi: 10.1182/blood-2007-10-116582

4. Zittoun RA, Mandelli F, Willemze R et al (1995) Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell’Adulto (GIMEMA) Leukemia Cooperative Groups. N Engl J Med 332:217–223. doi: 10.1056/NEJM199501263320403

5. Gale RP, Büchner T, Zhang MJ et al (1996) HLA-identical sibling bone marrow transplants vs chemotherapy for acute myelogenous leukemia in first remission. Leukemia 10:1687–1691

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3